Cancer Genomics & Metabolomics


Malignancy Genomics and Metabolomics. Malignancy genomics is a sub-field of genomics that exemplifies disease connected or malignancy related qualities. Though Metabolomics is the evaluation of little particles framed by metabolic movements inside an organic model. Metabolomics datasets contain an abundance of information that mirror the infection state and are resulting to both hereditary variety and climate. Since malignant growth is a genomic sickness, genomic profiling is an irrefutably significant instrument for accuracy oncology. Accuracy Oncology insinuates the fitting of remedial malignancy treatment to the singular characteristics of each quiet.


  • Cancer Metabolomics
  • Precision Oncology
  • Biomarker Metabolomics
  • Cancer immunotherapy
  • Active immunotherapies

Related Conference of Cancer Genomics & Metabolomics

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Cancer Genomics & Metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in